Skip to main content
News Icon

News categories: Honors & Funding

University of Bonn and ImmunoSensation² receive Henriette Herz-Price

Concept for attracting young international talent awarded

As one of eight universities in Germany, the University of Bonn was being awarded the Henriette Herz Prize by the Alexander von Humboldt Foundation. The university receives 125,000 euros for its concept for attracting internationally highly qualified young researchers.

"For years, attracting top international talent has also been more and more important in the university environment", explains Prof. Dr. Dr. h.c. Michael Hoch, the rector of the University of Bonn. "In the competition for the best talent, it is therefore essential to make our outstanding location advantages visible and to set the threshold for a location change as low as possible. We are very happy about this great success, thanks to which we can now implement this pilot project. "

With a bundle of various measures, international talents will be introduced to the work at the University of Bonn and in particular in the ImmunoSensation Cluster of Excellence. Talented women are also to be addressed in a targeted manner.

With virtual 360 ° campus tours and interactive laboratory visits, researchers can also get to know the excellence location from abroad. A digital roadshow with subsequent career fairs is intended to promote exchange and make it easier to make a decision to work at the University of Bonn. "These digital formats can only ever be the first step," explains Tina Odenthal from the International Office. "It was therefore important for us to include travel grants so that the young talents and their families can come straight to Bonn for one to two weeks. We want to achieve an intensive exchange with the researchers and a removal of possible hurdles for a change. " The pilot project is of great importance for the ImmunoSensation Cluster of Excellence. "For us as a cluster of excellence, recruiting top international talent is a particular concern," emphasizes Dr. Catherine Drescher from ImmunoSensation. "With this recruitment concept, we aim at a targeted exchange with talents and a knowledge transfer that is enriching for all parties."

Related news

Speakers of ImmunoSensation

News categories: Honors & Funding

ImmunoSensation goes into the next round

The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

News categories: Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry
Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry

Back to the news overview